China
· Delayed Price · Currency is CNY Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Statistics
Total Valuation
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. has a market cap or net worth of CNY 11.13 billion. The enterprise value is 11.99 billion.
| Market Cap | 11.13B |
| Enterprise Value | 11.99B |
Important Dates
The last earnings date was Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 24, 2024 |
Share Statistics
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. has 824.60 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 824.60M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 13.13% |
| Owned by Institutions (%) | 18.95% |
| Float | 554.72M |
Valuation Ratios
The trailing PE ratio is 122.62 and the forward PE ratio is 43.09.
| PE Ratio | 122.62 |
| Forward PE | 43.09 |
| PS Ratio | 3.90 |
| PB Ratio | 2.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.91, with an EV/FCF ratio of -71.71.
| EV / Earnings | 132.05 |
| EV / Sales | 4.20 |
| EV / EBITDA | 30.91 |
| EV / EBIT | 51.33 |
| EV / FCF | -71.71 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.58 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 2.18 |
| Debt / FCF | -5.05 |
| Interest Coverage | 2.91 |
Financial Efficiency
Return on equity (ROE) is 1.17% and return on invested capital (ROIC) is 2.29%.
| Return on Equity (ROE) | 1.17% |
| Return on Assets (ROA) | 1.72% |
| Return on Capital (ROIC) | 2.29% |
| Revenue Per Employee | 1.22M |
| Profits Per Employee | 38,917 |
| Employee Count | 2,333 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.90 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.66% in the last 52 weeks. The beta is 0.41, so Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -27.66% |
| 50-Day Moving Average | 12.76 |
| 200-Day Moving Average | 13.35 |
| Relative Strength Index (RSI) | 54.56 |
| Average Volume (20 Days) | 9,522,578 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Yantai Dongcheng Pharmaceutical Group Co.,Ltd. had revenue of CNY 2.85 billion and earned 90.79 million in profits. Earnings per share was 0.11.
| Revenue | 2.85B |
| Gross Profit | 1.21B |
| Operating Income | 233.57M |
| Pretax Income | 138.80M |
| Net Income | 90.79M |
| EBITDA | 378.49M |
| EBIT | 233.57M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 955.20 million in cash and 844.87 million in debt, giving a net cash position of 110.33 million or 0.13 per share.
| Cash & Cash Equivalents | 955.20M |
| Total Debt | 844.87M |
| Net Cash | 110.33M |
| Net Cash Per Share | 0.13 |
| Equity (Book Value) | 5.47B |
| Book Value Per Share | 5.46 |
| Working Capital | 970.54M |
Cash Flow
In the last 12 months, operating cash flow was 362.07 million and capital expenditures -529.26 million, giving a free cash flow of -167.19 million.
| Operating Cash Flow | 362.07M |
| Capital Expenditures | -529.26M |
| Free Cash Flow | -167.19M |
| FCF Per Share | -0.20 |
Margins
Gross margin is 42.29%, with operating and profit margins of 8.19% and 3.18%.
| Gross Margin | 42.29% |
| Operating Margin | 8.19% |
| Pretax Margin | 4.87% |
| Profit Margin | 3.18% |
| EBITDA Margin | 13.27% |
| EBIT Margin | 8.19% |
| FCF Margin | -5.86% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.91%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 0.91% |
| Dividend Growth (YoY) | -16.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 236.63% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.90% |
| Earnings Yield | 0.82% |
| FCF Yield | -1.50% |
Stock Splits
The last stock split was on August 30, 2016. It was a forward split with a ratio of 3.
| Last Split Date | Aug 30, 2016 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. has an Altman Z-Score of 3.11.
| Altman Z-Score | 3.11 |
| Piotroski F-Score | n/a |